Literature DB >> 22679261

Advanced and rapidly progressing head and neck cancer: good palliation following intralesional bleomycin.

Keith Ian Quintyne1, Shirley Baker, Fintan Wallis, Neville Shine, Rajnish Gupta.   

Abstract

The authors herein report the case of a 61-year-old man undergoing adjuvant therapy for locally advanced laryngeal cancer, who developed parastomal recurrence in his radiation field around his tracheotomy site, while he was undergoing radiation therapy, and compromised the secure placement of his tracheotomy tube and maintenance of his upper airway. MRI restaging and biopsy confirmed recurrence and progressive disease in his mediastinum. He underwent local therapy with intralesional bleomycin with good palliation, and ability to maintain the patency of his upper airway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22679261      PMCID: PMC3185391          DOI: 10.1136/bcr.08.2011.4599

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

Review 1.  Injectable modalities as local and regional strategies for head and neck cancer.

Authors:  G L Clayman; L K Dreiling
Journal:  Hematol Oncol Clin North Am       Date:  1999-08       Impact factor: 3.722

Review 2.  [Post total laryngectomy stomal recurrence. Case report and review of the literature].

Authors:  Jaime Alonso Reséndiz-Colosia; José Francisco Gallegos-Hernández; Martín Hernández-San Juan; Sinuhé Barroso-Bravo; Rutilio Flores-Díaz
Journal:  Cir Cir       Date:  2003 Sep-Oct       Impact factor: 0.361

3.  Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  V Grégoire; J-L Lefebvre; L Licitra; E Felip
Journal:  Ann Oncol       Date:  2010-05       Impact factor: 32.976

4.  The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck.

Authors:  D C Bloom; P M Goldfarb
Journal:  Eur J Surg Oncol       Date:  2005-09-08       Impact factor: 4.424

Review 5.  Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy.

Authors:  Ivan Marcelo Gonçalves Agra; Alfio Ferlito; Robert P Takes; Carl E Silver; Kerry D Olsen; Sandro J Stoeckli; Primož Strojan; Juan P Rodrigo; João Gonçalves Filho; Eric M Genden; Missak Haigentz; Avi Khafif; Randal S Weber; Peter Zbären; Carlos Suárez; Dana M Hartl; Alessandra Rinaldo; Kwang Hyun Kim; Luiz P Kowalski
Journal:  Head Neck       Date:  2011-04-11       Impact factor: 3.147

6.  Toxicity and response criteria of the Eastern Cooperative Oncology Group.

Authors:  M M Oken; R H Creech; D C Tormey; J Horton; T E Davis; E T McFadden; P P Carbone
Journal:  Am J Clin Oncol       Date:  1982-12       Impact factor: 2.339

Review 7.  Effective health care: management of head and neck cancers.

Authors:  R Collins; A Flynn; A Melville; R Richardson; A Eastwood
Journal:  Qual Saf Health Care       Date:  2005-04

8.  [Bleomycin emulsion for intralesional instillation in advanced oropharyngeal carcinomas. A case report on local bleomycin application].

Authors:  H A Merten; J F Hönig
Journal:  Dtsch Zahn Mund Kieferheilkd Zentralbl       Date:  1992

Review 9.  Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck.

Authors:  David J Arnold; W Jerry Goodwin; Donald T Weed; Francisco J Civantos
Journal:  Semin Radiat Oncol       Date:  2004-04       Impact factor: 5.934

10.  Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.

Authors:  Jeffrey S Tobias; Kathryn Monson; Nirmal Gupta; Hugh Macdougall; John Glaholm; Iain Hutchison; Latha Kadalayil; Allan Hackshaw
Journal:  Lancet Oncol       Date:  2009-10-29       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.